Stuart W Hicks

Stuart W Hicks is an experienced professional in the field of oncology research and translational medicine. Currently serving as Vice President of Oncology Research & Translation at Dragonfly Therapeutics, Inc., Stuart has held several significant positions, including Executive Director of Translational Medicine and Senior Director of Immuno-Oncology. Prior roles include Director of Oncology Research at bluebird bio, Director of Pipeline Research & Development and Associate Director at ImmunoGen, Inc., and Senior Research Scientist at Excelimmune, Inc. Stuart's academic background includes a postdoctoral fellowship at Yale University School of Medicine, highlighting a robust career dedicated to advancing cancer research.